About: Kineta Inc
Profile:
Posts by Kineta Inc:
- Kineta Presents New Preclinical Data and Phase 1/2 Clinical Trial Design of KVA12.1 at the Tumor Myeloid-Directed Therapies Summit (June 17, 2022 - Kineta Press Release)
- Puget Sound Business Journal: Seattle biotech Kineta to go public in reverse merger deal with Yumanity Therapeutics (June 7, 2022 - Biotech Industry News)
- Chief Financial Officer (June 7, 2022 - Current Openings)
- GeekWire: Seattle biotech Kineta will go public in deal with neurosciences company Yumanity Therapeutics (June 6, 2022 - Biotech Industry News)
- Kineta Announces Reverse Merger with NASDAQ listed Yumanity Therapeutics (YMTX) (June 6, 2022 - Biotech Industry News)
- Life Sciences Review Selects Kineta as Top Biotech Startup of 2022 (May 26, 2022 - Biotech Industry News)
- Kineta Presenting in Multiple Sessions at the Preclinical Immuno-oncology Online 2022 (May 18, 2022 - Kineta Press Release)
- Kineta Unveils New Preclinical Data on its Anti-CD27 Agonist Lead Antibodies at AACR 2022 (April 13, 2022 - Kineta Press Release)